Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,421–1,430 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1421
- Medicine slug
- sotalol
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 47
- Source count
- 47
- Agreement rate
- 0.617021
- Recorded readings
12 hours
- Numeric value
- 12
- Unit
- hours
- Source records
- 29
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 29 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f3145d7-f3c9-4456-a77d-d04c54f24668 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56326224-fc80-4b89-8ba3-70cb873173b4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56dd490f-4d78-447c-a460-f55587e8a764 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e2772cb-7dea-42d1-ba31-d479ba7cb09a (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8ac6351-b1e9-4dd2-82f2-5980814fda15 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6a7702f-36c9-45db-b640-453dc324baee (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:253da1e1-022a-4175-bd7f-e7673cba0767 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8d0daf3-5eab-44f1-9dec-40e5d9c2bbcf (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6acf10b5-bbd9-4993-99a9-2cdb8cec96c5 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44d0ce4c-de00-4151-ad7f-48a59040a9b0 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:667fc1f2-6ccf-4373-89d8-6a064ee7509e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a36d95c-6e93-4e57-befe-b5274f359244 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b534c632-3b67-4812-a045-3e582eda6de4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89b33c45-ece8-496f-9c3a-94ebabf73b1b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:517824b1-11be-40a9-9066-d1a6a32a2938 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
Distribution occurs to a central (plasma) and to a peripheral compartment, with a mean elimination half-life of 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6c8f659-1c32-4431-bdb2-3211a1c81006 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10b7b81d-9ce7-4025-8559-fdfa41c8b146 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ede17b7-3898-4f9f-abec-e15620cef76a (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
Distribution occurs to a central (plasma) and to a peripheral compartment, with a mean elimination half-life of 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f13a6dd-dd77-47c8-ac5d-4a746c32dbd0 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fd4afc7-dbf8-46be-9657-aa83bbb2c026 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff3061ab-d930-4318-a5be-684e38be229e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
Distribution With oral dosing, distribution occurs to a central (plasma) and to a peripheral compartment, with a mean elimination half-life of 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14ee4756-52f2-4bbf-bd79-663839ecb1c5 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ea445d-4d7c-4c32-83a7-e7683a56075b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6be8c8f2-3977-4b7f-ad45-38b3254afdab (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db9b0b36-4c00-45b6-a50a-e08d7c61a17c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31404462-7fa0-20d6-e063-6294a90aa58c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f33f900-0777-4a92-a7f7-00cf3d57d95c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbeaba9f-0513-4980-bc29-7f9259a53ecc (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0a34c56-9641-4592-9754-bcc233ec86b6 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
The mean elimination half-life of sotalol is 12 hours.
9.5 hours
- Numeric value
- 9.5
- Unit
- hours
- Source records
- 18
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 18 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a56c82e-7ecd-43b0-2899-f89e47adf7db (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:866e5717-3de2-4f19-b7c7-2275caeef78b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c824f6b2-80c5-45a6-a491-4c14c9f5e33d (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51cebe16-4496-4f49-b2db-b7b21c08fa23 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6674d53a-7137-4822-8841-4982f702a1b8 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe82c866-03d4-e07b-e053-6394a90a8b1e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27c73b70-99e8-40e8-8aa9-36d3addd3bb4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56879738-8662-4f5c-8386-761ab2b5e46f (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cb4879f-31e7-4862-bc0c-d439e592d81c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bc35a3e8-681c-4fe8-96cd-b2a62f024c4b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4614480b-b36e-4dbd-9fc0-d083890d297d (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f2ee505-eb90-885d-e063-6394a90a46a1 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:282b48b2-f9ff-474a-b01e-68a9ce5edf07 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f5902e1-9f9f-4c6b-817d-2efbb5e28061 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e005309-4eca-4536-8743-c6ed9e5b3195 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:876214ba-59c4-4acc-a8ad-c6bc91837de8 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2 to 3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5962c4ee-c8f7-4e38-ab8c-4848c7644362 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcbc1624-283e-732f-e053-2995a90a8f11 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After rapid absorption with peak levels occurring on average between 2–3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours.
Projected row 1422
- Medicine slug
- sotalol
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 47
- Source count
- 47
- Agreement rate
- 1
- Recorded readings
2.5 to 4 hours
- Numeric value
- 2.5
- Unit
- hours
- Source records
- 47
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 47 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f3145d7-f3c9-4456-a77d-d04c54f24668 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a56c82e-7ecd-43b0-2899-f89e47adf7db (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:866e5717-3de2-4f19-b7c7-2275caeef78b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c824f6b2-80c5-45a6-a491-4c14c9f5e33d (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56326224-fc80-4b89-8ba3-70cb873173b4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51cebe16-4496-4f49-b2db-b7b21c08fa23 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56dd490f-4d78-447c-a460-f55587e8a764 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6674d53a-7137-4822-8841-4982f702a1b8 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e2772cb-7dea-42d1-ba31-d479ba7cb09a (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8ac6351-b1e9-4dd2-82f2-5980814fda15 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6a7702f-36c9-45db-b640-453dc324baee (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe82c866-03d4-e07b-e053-6394a90a8b1e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27c73b70-99e8-40e8-8aa9-36d3addd3bb4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:253da1e1-022a-4175-bd7f-e7673cba0767 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8d0daf3-5eab-44f1-9dec-40e5d9c2bbcf (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6acf10b5-bbd9-4993-99a9-2cdb8cec96c5 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44d0ce4c-de00-4151-ad7f-48a59040a9b0 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:667fc1f2-6ccf-4373-89d8-6a064ee7509e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a36d95c-6e93-4e57-befe-b5274f359244 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b534c632-3b67-4812-a045-3e582eda6de4 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56879738-8662-4f5c-8386-761ab2b5e46f (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89b33c45-ece8-496f-9c3a-94ebabf73b1b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cb4879f-31e7-4862-bc0c-d439e592d81c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:517824b1-11be-40a9-9066-d1a6a32a2938 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (i.e., after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bc35a3e8-681c-4fe8-96cd-b2a62f024c4b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6c8f659-1c32-4431-bdb2-3211a1c81006 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10b7b81d-9ce7-4025-8559-fdfa41c8b146 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4614480b-b36e-4dbd-9fc0-d083890d297d (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ede17b7-3898-4f9f-abec-e15620cef76a (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (i.e., after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f13a6dd-dd77-47c8-ac5d-4a746c32dbd0 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f2ee505-eb90-885d-e063-6394a90a46a1 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:282b48b2-f9ff-474a-b01e-68a9ce5edf07 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fd4afc7-dbf8-46be-9657-aa83bbb2c026 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff3061ab-d930-4318-a5be-684e38be229e (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2-3 days (i.e., after 5-6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f5902e1-9f9f-4c6b-817d-2efbb5e28061 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14ee4756-52f2-4bbf-bd79-663839ecb1c5 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6ea445d-4d7c-4c32-83a7-e7683a56075b (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e005309-4eca-4536-8743-c6ed9e5b3195 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6be8c8f2-3977-4b7f-ad45-38b3254afdab (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:876214ba-59c4-4acc-a8ad-c6bc91837de8 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db9b0b36-4c00-45b6-a50a-e08d7c61a17c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5962c4ee-c8f7-4e38-ab8c-4848c7644362 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2–3 days (that is, after 5–6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31404462-7fa0-20d6-e063-6294a90aa58c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f33f900-0777-4a92-a7f7-00cf3d57d95c (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to3 days (that is, after 5-6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbeaba9f-0513-4980-bc29-7f9259a53ecc (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0a34c56-9641-4592-9754-bcc233ec86b6 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bcbc1624-283e-732f-e053-2995a90a8f11 (opens source in a new tab)
Sotalol label
Version not recorded · Effective date not recorded
After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2 to 3 days (that is, after 5 to 6 doses when administered twice daily).
Projected row 1423
- Medicine slug
- spironolactone
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 131
- Source count
- 131
- Agreement rate
- 0.916031
- Recorded readings
95.4%
- Numeric value
- 95.4
- Unit
- %
- Source records
- 120
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 120 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb27a2d2-1d28-4780-8e69-5fe613a0335e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:caf41e17-0461-4667-9eab-62853b945131 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15641f17-a08e-432b-ab8f-13db623e612e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4514fa40-613e-46f5-bee4-3edc7cc9863f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c450e66a-0f05-445e-b1df-df2b17a2f064 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9b79b4a-1a48-6247-e053-6394a90a2ae1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c328f555-2da8-43ac-bc04-0e89d4d2aa53 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45232668-6952-80a0-e063-6294a90a6e4b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f988aa11-60ed-411e-e053-6294a90a522a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c223a334-7383-429f-b8e3-a21200f16962 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c31c953-05ce-475a-b93f-80aeb12bde95 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f0291a9-c8a6-4298-a540-23abc01fae09 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c42b3e-f076-49d9-aa61-6cef0dbb5543 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffd2f3f5-c7c8-0028-e053-6394a90aaf17 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:985524c3-9fb3-4874-9eb6-80b17af3d8ed (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e1a8152-941a-4aa4-bcb0-83c04905678f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of Food Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e456f3c-f93e-41c6-80c5-a737ed70feda (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:951b8948-dc0f-4aef-9910-82c252de936d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4239da9e-dd0c-9af0-e063-6394a90a3cbb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beaf74db-4159-3b59-ef99-575c3ac99aa1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of Food Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb1423e8-1517-44c5-98e0-99be24ce269b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3487305c-25a6-4e82-923c-3e4dd638c988 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be4aa233-1555-4972-858e-46343a710558 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebc4efec-7895-4298-8e75-360bb7992f8d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7646ca22-710e-4a5c-9613-b829e2f9d5ce (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b9a20c4-46f2-d572-e063-6294a90a30ad (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb66327e-8261-46ae-b39a-4fa79d520844 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d747bf5-31aa-48a5-9c6d-3cf8ce99a8f1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cc23419-e6d5-4036-8011-dc1d2455e0cb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37b9bc61-2757-454a-935b-752d13eb7eb4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98cc3be-cf59-e3d2-e053-6294a90a2ae0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c45d793-6f2f-4622-b5ed-6875acfbc02b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:768563dc-a619-44dc-b97f-1a7e71fd56a0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b4af7e0-f35b-9bf6-e063-6294a90a83b9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:731894f2-bb1b-4ff6-b8c4-b8722e173199 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56050192-c499-64bd-e063-6294a90acbeb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1c5fdab-3ff7-414b-8e25-beed8311b8ad (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5b129b8-aed9-4d94-a35e-e92647effbdb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:416ce231-fc8d-4ba0-a1ce-d5e054cf025e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ef0c2bb-9657-419e-848c-858893be50bc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffd1ed7a-b6a4-4240-e053-6394a90a7db1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e5e782d-9ceb-d4a4-e063-6294a90aba3a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb29ea6f-c294-4895-9e9b-544d69651a35 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6867776e-b4fd-41db-8da8-a5af76eed280 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10a5c989-66e3-494d-bfd8-b2d6df3be411 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db22e9e5-2d88-4712-a809-c00881edb447 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e61269b2-823a-49e8-b55f-ef0b8b1dbcde (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d06acd-1351-4afd-a16a-f035758e2a27 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73564b3d-8ede-4008-b75c-1277153b5bb6 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e34fc3ca-1272-446b-8dc2-25b62add01c3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd64e343-e15e-43b1-88b5-a3d5ba23fedf (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:200b2a6a-f263-463e-a2e1-f4f74058a924 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48115c9e-c82f-438d-b178-dce1b73687db (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of Food Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472ee2ad-7e57-bef1-e063-6394a90a0206 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce792c44-421d-4274-a333-01e2297ee0a3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of Food Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2efb4720-625f-6616-b6f0-8b13a17c9d7e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb314e91-6dd5-4bdb-af35-5d147b20339c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f32e8109-73e1-a249-e053-2995a90a3fae (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be568fbd-3c3d-417c-ae96-75a78ca4b7cd (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:791251af-d276-40fc-8c35-9d179b20e219 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6e0bf0e-42d3-41e4-854b-811df3bbaaa9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd5ec154-b092-4c4d-8e72-ca2a2ef71a6d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b29888c-09f9-4cd5-9b4c-920bd159a727 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4290b3ec-8993-47d4-bfe3-fcb81d7baed8 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc817de-5ea8-4139-9c13-02bac8ff93c3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3791d79c-d960-4790-b689-ea32ddf7226a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:753bbc6f-2e50-49c1-b5bf-18f8411a1e8e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:813d199a-9004-4102-8ade-cf877caedafb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac487ae2-e15f-4781-bae3-a03058cfcfe4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7057c090-67c2-414c-9077-bed18ad4b0b3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of Food Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8cbe2215-744c-438a-b3d6-b7d6ae769231 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c23b6b9b-aec3-48a8-a518-76e4097f6479 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b119ed8a-289a-46c5-9778-6b07e4c061c4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a66d90e-5450-4716-8c01-e7dc1967d00d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:860b08bf-c6c1-4310-8510-10b6779f3d59 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b119e3-537a-464c-9376-4219bf283753 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18f11eed-9ef6-43f6-8db0-720c27563871 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a73e3dd9-4958-4a2c-853f-45b2810b1639 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b60de71-2afa-4922-ba3e-0664c2ae29a0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39d82d50-0b77-4ef5-96b8-c1e05044a82c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08738ad4-1607-4d55-af71-6790477353bd (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963af399-feb7-49d2-a59c-c19edad9c682 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab3090fc-458c-17c1-e053-2995a90a6ffa (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7a1f1d6-0724-4ad9-a4f9-7b1fe910f95d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6782c1c1-d1ac-4c07-b7cb-a74699d2f9fe (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f76b37a6-bcd4-2c8a-e053-6394a90aceea (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b76a904-6c99-485a-a05f-13a36c5f720c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0efa529-2870-4260-b604-2f30e2cbb87b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57d1c333-c229-54aa-e063-6394a90a84ce (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34b19a23-4595-417e-9592-fd1d69398e59 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf58378f-8304-4799-b0c0-fad8697149ab (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:781e0f31-a7c8-4a05-bb38-88f6dd874746 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7510768-8a52-4230-6aa0-b0d92d82588f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:574efac6-b2d9-4053-940c-552f01a69b2e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66c46ede-4f56-436a-993b-006b4eb56fc3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99bbc053-0e41-4b4d-979a-db610908f2de (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4cf1136-df3a-4fc2-9a21-9032949eca41 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae0dcb4e-63df-459c-8e60-0caa817b8135 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca194a2a-ed16-40f6-a78c-45c5f3392170 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59d86d3a-0f94-0b04-e063-6294a90a83f3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fed2822-3a03-4b64-9857-c682fcd462bc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb961096-edbb-45ad-96b7-61c2f9b98cf9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b98b7780-e310-493a-83bd-bb3d93cf8dde (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffc2e9b4-1f0f-220c-e053-6294a90a6d75 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96db5dee-7c01-4f96-8b1e-1fcd2103d0fe (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ed347bc-a9f1-4800-99bc-9af9912ead1f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d0655d7-fda6-40c6-907c-acaba0e19987 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31aeab13-8f71-49f1-b101-8b0abb21b0dc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6518ba72-89e4-4f2f-b334-9ef759b696f8 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37066684-5b63-4d3e-ae6a-08c4b3edd7aa (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1fe93db1-0012-4ff6-a4e6-04e2d7e9f638 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6138536-cdc1-4459-84ff-9dedc0de1105 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c59e03a-b058-4f6e-b104-0836d9b56392 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b68235bb-0940-4810-bbf4-2a7a0881de68 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a96e2c9-049a-43ab-abf3-21baedeb736f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:852684dc-e1c6-4caa-bccb-10ac90bbb3bb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cae68fd6-5161-4650-bcde-6db98cbe6c8b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473dc80f-11b7-46bf-b0b4-7a271444fca2 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53454970-2c0f-54c3-e063-6294a90aac0a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : Food increased the bioavailability of spironolactone (as measured by AUC) by approximately 95.4%.
100%
- Numeric value
- 100
- Unit
- %
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f230f1fa-878e-4753-a16c-bf059b59cdef (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dffac5dc-a111-4095-a96c-54cc5c3866e5 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:caf9c845-63eb-40bd-8261-0582abdf705a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:691bc5ca-5d5e-60c2-e053-2991aa0abb93 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:540ee876-78fb-1792-e054-00144ff88e88 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c2ae130-8e84-4c3f-b190-82691312fcbd (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c97ce61-8e49-4724-a636-d179479d346c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Food increased the bioavailability of unmetabolized spironolactone by almost 100%.
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:522bd365-ddcc-48f4-8a98-66dc4c3bb314 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: A high fat and high calorie meal (57% of the ~1000 kcal of the meal were from fat) increased the bioavailability of spironolactone (as measured by AUC) by approximately 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:122558a0-57bb-4195-9adf-d37b049cbfb5 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: A high fat and high calorie meal (57% of the ~1000 kcal of the meal were from fat) increased the bioavailability of spironolactone (as measured by AUC) by approximately 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ac2926a-949a-4383-b0b0-92c0822dfcda (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food : A high fat and high calorie meal (57% of the ~1000 kcal of the meal were from fat) increased the bioavailability of spironolactone (as measured by AUC) by approximately 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed9a2cb-d666-43db-b515-f9615fa6da25 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Effect of food: A high fat and high calorie meal (57% of the ~1,000 kcal of the meal were from fat) increased the bioavailability of spironolactone (as measured by AUC) by approximately 90%.
Projected row 1424
- Medicine slug
- spironolactone
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 131
- Source count
- 124
- Agreement rate
- 0.967742
- Recorded readings
1.4 hour
- Numeric value
- 1.4
- Unit
- hours
- Source records
- 120
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 120 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb27a2d2-1d28-4780-8e69-5fe613a0335e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:caf41e17-0461-4667-9eab-62853b945131 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15641f17-a08e-432b-ab8f-13db623e612e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4514fa40-613e-46f5-bee4-3edc7cc9863f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c450e66a-0f05-445e-b1df-df2b17a2f064 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9b79b4a-1a48-6247-e053-6394a90a2ae1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c328f555-2da8-43ac-bc04-0e89d4d2aa53 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45232668-6952-80a0-e063-6294a90a6e4b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f988aa11-60ed-411e-e053-6294a90a522a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c223a334-7383-429f-b8e3-a21200f16962 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c31c953-05ce-475a-b93f-80aeb12bde95 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f0291a9-c8a6-4298-a540-23abc01fae09 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c42b3e-f076-49d9-aa61-6cef0dbb5543 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-β-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffd2f3f5-c7c8-0028-e053-6394a90aaf17 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:985524c3-9fb3-4874-9eb6-80b17af3d8ed (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e1a8152-941a-4aa4-bcb0-83c04905678f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e456f3c-f93e-41c6-80c5-a737ed70feda (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:951b8948-dc0f-4aef-9910-82c252de936d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4239da9e-dd0c-9af0-e063-6394a90a3cbb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beaf74db-4159-3b59-ef99-575c3ac99aa1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb1423e8-1517-44c5-98e0-99be24ce269b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3487305c-25a6-4e82-923c-3e4dd638c988 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be4aa233-1555-4972-858e-46343a710558 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebc4efec-7895-4298-8e75-360bb7992f8d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7646ca22-710e-4a5c-9613-b829e2f9d5ce (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b9a20c4-46f2-d572-e063-6294a90a30ad (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb66327e-8261-46ae-b39a-4fa79d520844 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d747bf5-31aa-48a5-9c6d-3cf8ce99a8f1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cc23419-e6d5-4036-8011-dc1d2455e0cb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37b9bc61-2757-454a-935b-752d13eb7eb4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98cc3be-cf59-e3d2-e053-6294a90a2ae0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c45d793-6f2f-4622-b5ed-6875acfbc02b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:768563dc-a619-44dc-b97f-1a7e71fd56a0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b4af7e0-f35b-9bf6-e063-6294a90a83b9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:731894f2-bb1b-4ff6-b8c4-b8722e173199 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56050192-c499-64bd-e063-6294a90acbeb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1c5fdab-3ff7-414b-8e25-beed8311b8ad (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5b129b8-aed9-4d94-a35e-e92647effbdb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:416ce231-fc8d-4ba0-a1ce-d5e054cf025e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ef0c2bb-9657-419e-848c-858893be50bc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffd1ed7a-b6a4-4240-e053-6394a90a7db1 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e5e782d-9ceb-d4a4-e063-6294a90aba3a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb29ea6f-c294-4895-9e9b-544d69651a35 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6867776e-b4fd-41db-8da8-a5af76eed280 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10a5c989-66e3-494d-bfd8-b2d6df3be411 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db22e9e5-2d88-4712-a809-c00881edb447 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e61269b2-823a-49e8-b55f-ef0b8b1dbcde (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d06acd-1351-4afd-a16a-f035758e2a27 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73564b3d-8ede-4008-b75c-1277153b5bb6 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e34fc3ca-1272-446b-8dc2-25b62add01c3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd64e343-e15e-43b1-88b5-a3d5ba23fedf (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:200b2a6a-f263-463e-a2e1-f4f74058a924 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48115c9e-c82f-438d-b178-dce1b73687db (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:472ee2ad-7e57-bef1-e063-6394a90a0206 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce792c44-421d-4274-a333-01e2297ee0a3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2efb4720-625f-6616-b6f0-8b13a17c9d7e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb314e91-6dd5-4bdb-af35-5d147b20339c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f32e8109-73e1-a249-e053-2995a90a3fae (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be568fbd-3c3d-417c-ae96-75a78ca4b7cd (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:791251af-d276-40fc-8c35-9d179b20e219 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-β-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6e0bf0e-42d3-41e4-854b-811df3bbaaa9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd5ec154-b092-4c4d-8e72-ca2a2ef71a6d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b29888c-09f9-4cd5-9b4c-920bd159a727 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4290b3ec-8993-47d4-bfe3-fcb81d7baed8 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc817de-5ea8-4139-9c13-02bac8ff93c3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3791d79c-d960-4790-b689-ea32ddf7226a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:753bbc6f-2e50-49c1-b5bf-18f8411a1e8e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:813d199a-9004-4102-8ade-cf877caedafb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac487ae2-e15f-4781-bae3-a03058cfcfe4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7057c090-67c2-414c-9077-bed18ad4b0b3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8cbe2215-744c-438a-b3d6-b7d6ae769231 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c23b6b9b-aec3-48a8-a518-76e4097f6479 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b119ed8a-289a-46c5-9778-6b07e4c061c4 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a66d90e-5450-4716-8c01-e7dc1967d00d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:860b08bf-c6c1-4310-8510-10b6779f3d59 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99b119e3-537a-464c-9376-4219bf283753 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18f11eed-9ef6-43f6-8db0-720c27563871 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a73e3dd9-4958-4a2c-853f-45b2810b1639 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b60de71-2afa-4922-ba3e-0664c2ae29a0 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39d82d50-0b77-4ef5-96b8-c1e05044a82c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08738ad4-1607-4d55-af71-6790477353bd (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:963af399-feb7-49d2-a59c-c19edad9c682 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab3090fc-458c-17c1-e053-2995a90a6ffa (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7a1f1d6-0724-4ad9-a4f9-7b1fe910f95d (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6782c1c1-d1ac-4c07-b7cb-a74699d2f9fe (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f76b37a6-bcd4-2c8a-e053-6394a90aceea (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b76a904-6c99-485a-a05f-13a36c5f720c (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0efa529-2870-4260-b604-2f30e2cbb87b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57d1c333-c229-54aa-e063-6394a90a84ce (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34b19a23-4595-417e-9592-fd1d69398e59 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf58378f-8304-4799-b0c0-fad8697149ab (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:781e0f31-a7c8-4a05-bb38-88f6dd874746 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7510768-8a52-4230-6aa0-b0d92d82588f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:574efac6-b2d9-4053-940c-552f01a69b2e (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66c46ede-4f56-436a-993b-006b4eb56fc3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99bbc053-0e41-4b4d-979a-db610908f2de (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4cf1136-df3a-4fc2-9a21-9032949eca41 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae0dcb4e-63df-459c-8e60-0caa817b8135 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca194a2a-ed16-40f6-a78c-45c5f3392170 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59d86d3a-0f94-0b04-e063-6294a90a83f3 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fed2822-3a03-4b64-9857-c682fcd462bc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb961096-edbb-45ad-96b7-61c2f9b98cf9 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b98b7780-e310-493a-83bd-bb3d93cf8dde (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffc2e9b4-1f0f-220c-e053-6294a90a6d75 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96db5dee-7c01-4f96-8b1e-1fcd2103d0fe (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ed347bc-a9f1-4800-99bc-9af9912ead1f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d0655d7-fda6-40c6-907c-acaba0e19987 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31aeab13-8f71-49f1-b101-8b0abb21b0dc (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6518ba72-89e4-4f2f-b334-9ef759b696f8 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37066684-5b63-4d3e-ae6a-08c4b3edd7aa (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.The mean half-life values of its metabolites including canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) are 16.5, 13.8, and 15 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1fe93db1-0012-4ff6-a4e6-04e2d7e9f638 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6138536-cdc1-4459-84ff-9dedc0de1105 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c59e03a-b058-4f6e-b104-0836d9b56392 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b68235bb-0940-4810-bbf4-2a7a0881de68 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a96e2c9-049a-43ab-abf3-21baedeb736f (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:852684dc-e1c6-4caa-bccb-10ac90bbb3bb (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cae68fd6-5161-4650-bcde-6db98cbe6c8b (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473dc80f-11b7-46bf-b0b4-7a271444fca2 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53454970-2c0f-54c3-e063-6294a90aac0a (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The mean half-life of spironolactone is 1.4 hour.
1- 2 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:522bd365-ddcc-48f4-8a98-66dc4c3bb314 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The half-life of spironolactone is approximately 1- 2 hour, and the half-life of canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) ranged from 10 to 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:122558a0-57bb-4195-9adf-d37b049cbfb5 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The half-life of spironolactone is approximately 1- 2 hour, and the half-life of canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) ranged from 10 to 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ac2926a-949a-4383-b0b0-92c0822dfcda (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The half-life of spironolactone is approximately 1 to 2 hour, and the half-life of canrenone, 7-α- (thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) ranged from 10 to 35 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed9a2cb-d666-43db-b515-f9615fa6da25 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Elimination The half-life of spironolactone is approximately 1 to 2 hour, and the half-life of canrenone, 7-α-(thiomethyl) spirolactone (TMS), and 6-ß-hydroxy-7-α-(thiomethyl) spirolactone (HTMS) ranged from 10 to 35 hours.
Projected row 1425
- Medicine slug
- spironolactone
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 131
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
0.5 to 1.5 hours
- Numeric value
- 0.5
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:522bd365-ddcc-48f4-8a98-66dc4c3bb314 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Absorption The peak plasma concentration (C max ) of spironolactone is reached 0.5 to 1.5 hours after dosing in healthy volunteers; for the active metabolite canrenone, the C max is reached around 2.5 to 5 hours after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:122558a0-57bb-4195-9adf-d37b049cbfb5 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Absorption The peak plasma concentration (C max ) of spironolactone is reached 0.5 to 1.5 hours after dosing in healthy volunteers; for the active metabolite canrenone, the C max is reached around 2.5 to 5 hours after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ac2926a-949a-4383-b0b0-92c0822dfcda (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Absorption The peak plasma concentration (C max ) of spironolactone is reached 0.5 to 1.5 hours after dosing in healthy volunteers; for the active metabolite canrenone, the C max is reached around 2.5 to 5 hours after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ed9a2cb-d666-43db-b515-f9615fa6da25 (opens source in a new tab)
Spironolactone label
Version not recorded · Effective date not recorded
Absorption The peak plasma concentration (C max ) of spironolactone is reached 0.5 to 1.5 hours after dosing in healthy volunteers; for the active metabolite canrenone, the C max is reached around 2.5 to 5 hours after dosing.
Projected row 1426
- Medicine slug
- sugammadex
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 22
- Source count
- 21
- Agreement rate
- 1
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 21
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 21 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f90c37e-3505-0968-38fd-fc7e4dd66e82 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55b2eb4e-4d77-c555-e063-6294a90abf9e (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0379799d-b678-4eb1-8f15-7dd183ee2a6e (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9d4467c-97ae-462a-9722-cc8d62db3e83 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21028965-598b-4cfa-a614-5c28ed40306a (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:579a2a1f-4d0c-4851-e063-6294a90a2be6 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f2e66d7-a5d2-4593-bb30-6d4a418381aa (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b25f16e-726a-4464-88da-b188c2f4e038 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70c00636-d4ba-4939-802c-9d5a92435c93 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e685b67-6804-4d97-b43e-0259b3fe231f (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9adda802-fab2-40c1-9c2f-358debdfb249 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c61ee55a-e61b-4d3c-9ebc-cbf57290e36c (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cf43d88-d410-439e-a2e5-e31086f14fc2 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f1c7cf8-3db7-3f92-e063-6394a90aece9 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7897fc1-4553-460c-a29b-0bc91cd9ca10 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab41ea1c-266f-421c-8fc4-6e7ff518a75d (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8c1dccf-9be3-49b2-a5d9-46c2b9ca0193 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37276948-ff0f-e0ab-e063-6394a90a0973 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e3eb206-5c35-2c93-e053-2a95a90a9df0 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5171d883-fe8f-482c-97ab-40b00975b64a (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb84def8-933b-4eba-b81f-30d40b1e3d8d (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Elimination In adult anesthetized patients with normal renal function, the elimination half-life (t 1/2 ) of sugammadex is about 2 hours and the estimated plasma clearance is about 88 mL/min (based on compartmental pharmacokinetic analysis).
Projected row 1427
- Medicine slug
- sugammadex
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 22
- Source count
- 21
- Agreement rate
- 1
- Recorded readings
11 to 14 liters
- Numeric value
- 11
- Unit
- L
- Source records
- 21
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 21 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f90c37e-3505-0968-38fd-fc7e4dd66e82 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55b2eb4e-4d77-c555-e063-6294a90abf9e (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distributio n The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0379799d-b678-4eb1-8f15-7dd183ee2a6e (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9d4467c-97ae-462a-9722-cc8d62db3e83 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21028965-598b-4cfa-a614-5c28ed40306a (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:579a2a1f-4d0c-4851-e063-6294a90a2be6 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f2e66d7-a5d2-4593-bb30-6d4a418381aa (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b25f16e-726a-4464-88da-b188c2f4e038 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70c00636-d4ba-4939-802c-9d5a92435c93 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e685b67-6804-4d97-b43e-0259b3fe231f (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9adda802-fab2-40c1-9c2f-358debdfb249 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c61ee55a-e61b-4d3c-9ebc-cbf57290e36c (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cf43d88-d410-439e-a2e5-e31086f14fc2 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f1c7cf8-3db7-3f92-e063-6394a90aece9 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7897fc1-4553-460c-a29b-0bc91cd9ca10 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab41ea1c-266f-421c-8fc4-6e7ff518a75d (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8c1dccf-9be3-49b2-a5d9-46c2b9ca0193 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37276948-ff0f-e0ab-e063-6394a90a0973 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e3eb206-5c35-2c93-e053-2a95a90a9df0 (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5171d883-fe8f-482c-97ab-40b00975b64a (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb84def8-933b-4eba-b81f-30d40b1e3d8d (opens source in a new tab)
Sugammadex label
Version not recorded · Effective date not recorded
Distribution The observed steady-state volume of distribution of sugammadex is approximately 11 to 14 liters in adult patients with normal renal function (based on conventional, non-compartmental pharmacokinetic analysis).
Projected row 1428
- Medicine slug
- sulfacetamide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 35
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
7 to 13 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fa7399b-4ced-492d-b6f6-cf155764087a (opens source in a new tab)
Sulfacetamide label
Version not recorded · Effective date not recorded
The biological half-life has been reported to be between 7 to 13 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66ab38ea-5cea-47be-97f2-486517999fb0 (opens source in a new tab)
Sulfacetamide label
Version not recorded · Effective date not recorded
The biological half-life has been reported to be between 7 to 13 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4fb4d39a-330e-4c84-abbc-3b33b36b206f (opens source in a new tab)
Sulfacetamide label
Version not recorded · Effective date not recorded
The biological half-life has been reported to be between 7 to 13 hours.
Projected row 1429
- Medicine slug
- sulfadiazine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
38%
- Numeric value
- 38
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8993651b-fff6-4e3f-9b60-78587bc9bcee (opens source in a new tab)
Sulfadiazine label
Version not recorded · Effective date not recorded
Protein binding is 38% to 48%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6032d6f7-cbce-4e5d-841c-a1e24b616f91 (opens source in a new tab)
Sulfadiazine label
Version not recorded · Effective date not recorded
Protein binding is 38% to 48%.
Projected row 1430
- Medicine slug
- sulfasalazine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 14
- Source count
- 14
- Agreement rate
- 1
- Recorded readings
15%
- Numeric value
- 15
- Unit
- %
- Source records
- 14
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 14 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:257cee60-b68f-4c2b-b57d-8e4d73d17e09 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9ef541a-93c8-4428-ba45-398aa0b327d1 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32fd1726-ed81-4441-9594-3aecf2db1dbf (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d596ac59-b643-4181-80ba-f2db1cc3459c (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88441a9f-b4f9-455d-a355-46fb30699a7b (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3254432e-87a4-4af0-afd1-d9e6f1b0efd4 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf5137fe-60ed-4497-8521-eeb0a684fabf (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76b532a3-e7ca-4929-8c51-c0f66e0806a8 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a54b31cc-205d-43d3-a850-acf4b41fbc37 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:029716bd-ee1a-484c-bf1f-ec8d02d5281b (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:618c5324-d0a6-4d00-9b12-0de88a71c180 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c59593b-e1a5-47cb-a82b-3e5e49205344 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48fbc535-a33a-45ee-85ff-9d1ec9b31d9c (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddbe69f3-bd55-45f3-a64f-f60226c744c4 (opens source in a new tab)
Sulfasalazine label
Version not recorded · Effective date not recorded
Pharmacokinetics In vivo studies have indicated that the absolute bioavailability of orally administered SSZ is less than 15% for parent drug.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1420Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.